Prostate Cancer Awareness Month

Prostate Cancer Awareness Month is observed throughout September as a time to raise awareness about prostate cancer, encourage informed conversations, and support the many people and families affected by the disease. The observance highlights the importance of learning about risk factors, recognizing questions to discuss with a healthcare professional, and making informed decisions about screening and care.

Throughout the month, communities, health organizations, and individuals help share reliable information, promote compassion, and honor those whose lives have been touched by prostate cancer. It is also an opportunity to support research, celebrate survivors, and remind loved ones that early, open conversations can play an important role in navigating health decisions.

Prostate Cancer Awareness Month is observed throughout September to raise public understanding of prostate cancer, its risk factors, detection, treatment, and effects on patients and families. The observance emerged in the United States during the late 1990s, when urological and cancer organizations were seeking a sustained period for public education rather than relying solely on individual awareness campaigns. The American Foundation for Urological Disease—now known as the Urology Care Foundation—is widely credited with helping establish the September observance in 1999.

Its development reflected growing attention to prostate cancer as a major public-health concern. Prostate cancer is one of the most commonly diagnosed cancers among men, and the risk of developing it increases with age. Awareness efforts initially concentrated on encouraging men to learn about prostate health and discuss screening with health professionals, particularly because prostate-specific antigen (PSA) testing and other methods of early detection have benefits as well as limitations. Over time, public information has increasingly emphasized informed, individualized decisions rather than presenting screening as appropriate in exactly the same way for everyone.

The observance has also evolved alongside advances in diagnosis and treatment. Campaigns now commonly address active surveillance for some lower-risk cancers, improvements in surgery and radiation therapy, newer medicines for advanced disease, survivorship, and the physical and emotional effects of treatment. Research fundraising has become another important feature, supporting work on earlier detection, precision medicine, treatment-resistant disease, and better outcomes for patients whose cancer is diagnosed at an advanced stage.

Culturally, Prostate Cancer Awareness Month has helped make conversations about prostate health more visible and has encouraged men to discuss symptoms, family history, and personal risk with medical professionals. It has also drawn attention to unequal outcomes, including the greater risk faced by Black men and the need for culturally responsive education and equitable access to care. Through educational programs, blue-themed campaigns, patient-support activities, fundraising, and community outreach throughout September, the observance connects personal health decisions with broader efforts to reduce mortality and improve the quality of life for those affected by prostate cancer.